# Lancaster Colony Corporation (LANC) — Financial Analysis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/LANC/thesis · /stocks/LANC/memo

## Financial Snapshot

---
step: 04
title: Financial Snapshot
ticker: LANC
current_ticker: MZTI
source: coverage-next-full
generated: 2026-05-28
---

### Step 04 — Financial Snapshot

#### Key Findings

- **Revenue trajectory:** FY19 $1,308M → FY25 $1,909M = 6.5% CAGR; FY21–FY25 = 6.8% CAGR (post-acquisitions/post-divestitures cleanup) [S1].
- **Margin recovery is real:** GM bottomed at 21.2% FY22 during ERP go-live + commodity peak, recovered to 23.9% FY25 (+270bps) and 24.8% 9M FY26 (+90bps further); structural ceiling estimated ~25–26% [S1][S5].
- **FCF re-expanded:** FY22 −$30M (capex spike) → FY25 $204M (10.7% of revenue); on track for ~$220M FY26 with capex normalizing [S1].
- **Balance sheet remains pristine:** $162M cash, $43M long-term debt = $118M net cash position at FY25 end; share count essentially flat (~27.5M diluted weighted) over 7 years [S1].
- **ROIC ~19.5% FY25** (NOPAT $172M / Invested Capital $880M) — top-quartile vs. CPG peer median ~10–12%; consistent with quality-compounder economics [S1].

#### Implications for Thesis and Valuation

The financial snapshot validates the "quality compounder" thesis pillar from Step 00: above-WACC ROIC sustained for 5+ years, FCF conversion >85%, debt-free balance sheet, dividend grown each year. The FY22 trough is contextually explainable (one-time ERP + commodity confluence), not a structural break. Recent margin recovery is steady; the FY26 9M data show the trajectory continuing. For Step 14's DCF, a base case of ~6–7% revenue CAGR through FY28, GM stabilizing at 24–25%, and FCF margin holding 10–11% would be consistent with current trajectory.

#### Objective

Establish the headline financial fact pattern (revenue, margins, EPS, FCF, balance sheet, ROIC) at a glance, with cross-checks across XBRL data, the 10-K, and StockAnalysis.com to confirm internal consistency. Calibrate the financial pillars referenced throughout subsequent steps.

#### Narrative Analysis

##### Top-Line Trajectory

7-year revenue CAGR FY19–FY25 is 6.5%, of which roughly half is pricing (especially FY22–FY23 inflation pass-through) and half is volume + mix (capacity adds, share gains in frozen breads, license partner expansion). FY26 9M growth +2.2% is decelerating as inflation tailwinds cycle out; Foodservice growing 5% pa is offsetting Retail flat-to-down. No transcripts available, but press releases consistently flag the volume pivot as the next-12-months challenge.

##### Gross Margin Story

Three distinct phases:
- **FY19–FY21:** 25–26% GM "normal" pre-inflation era.
- **FY22–FY23:** 21% trough — concurrent (a) ERP go-live disruption with parallel-run costs, (b) soybean oil at 15-year highs (Russia/Ukraine impact + biofuel demand), (c) packaging/freight inflation. The trough was real and 4–5pp deep.
- **FY24–FY26:** 23–25% recovery as pricing flows through, ERP transitions to optimization, and commodity costs moderate.

The Marzetti Way Optimization Plan (launched FY24) is the explicit cost program targeting GM normalization. Q3 FY26 GM 23.6% reported (24.4% on Adjusted basis ex-TSA, per Q3 8-K) — within striking distance of pre-inflation GM but not yet there.

##### Operating Margin

Op income FY25 $220M = 11.5% OpM. Trajectory: FY22 6.7% trough → FY24 10.7% → FY25 11.5% → FY26 9M 12.4% (run-rate). SG&A discipline is real: SG&A grew 12% over FY22–FY25 while revenue grew 14% — modest positive operating leverage. Restructuring/impairment charges are limited in scale (sub-$5M annually).

##### Cash Flow and Capital Discipline

- OCF FY25 $261M (13.7% of sales); 7-year average OCF margin ~12.5%.
- Capex normalized: FY22 peak $132M (ERP + capacity build) → FY25 $58M (3.0% of sales). This is the central capex story — the heavy capital cycle is behind the company.
- FCF FY25 $204M (10.7% of sales); covers dividends ($103.5M) ~2.0x, leaving ~$100M for M&A + buybacks.
- Working capital remains a moderate sales drag (inventory $169M = 89 days; AP $118M = 62 days), but normalizing post-COVID.

##### Balance Sheet

- **Cash:** $161.5M FY25 end → $218M Q3 FY26 end (8-K).
- **LT debt:** $42.7M FY25 (finance leases + mortgages; no bank or bond debt).
- **Net cash:** $118M FY25, $175M Q3 FY26 (pre-Bachan's close May 1, 2026).
- **Equity:** $999M FY25 retained earnings $1,629M; book value/share ~$36 — book yield deeply negative vs. price suggesting market values intangibles and franchise.
- **Shares outstanding:** 27,547,758 (Sep 22, 2025) — flat over 7 years; ~$8–10M annual buybacks essentially offset SBC.

##### ROIC Calculation FY25

| Component | Value |
|---|---|
| Operating Income | $220.3M |
| Tax rate | 22% |
| NOPAT | $172M |
| Equity | $998.5M |
| LT Debt | $42.7M |
| Cash | ($161.5M) |
| **Invested Capital** | **$879.7M** |
| **ROIC** | **19.5%** |

Reverse-checked against alternative definitions:
- ROIC ex-cash (cash treated separately): 19.6%
- ROCE: 24% (NOPAT / Equity)
- CROIC (CFO − Capex / IC): 23%

All metrics signal durable above-WACC returns; entry A14 in the assumption register.

##### Accounting Quality

- No restatements identified in inventory of filings.
- Auditor unchanged (Deloitte & Touche, multi-year).
- D&A: $62M FY25 = 3.3% of revenue, consistent with PP&E gross $1.2B and average asset life 18 years.
- SBC: $9M FY25 = 0.5% of revenue — small, fully expensed.
- No off-balance-sheet items disclosed.
- Adjusted vs. GAAP gap: minor; Q3 FY26 disclosure of $0.5M TSA exit cost is the most visible adjustment.

A09 (no material accounting irregularities) confirmed.

#### Evidence and Sources

XBRL company facts for all financial data points [S1]; FY25 10-K MD&A + financial statements [S3]; Q3 FY26 8-K balance sheet + Adj margin reconciliation [S4]; StockAnalysis.com cross-check on annual statements [S5].

#### Assumption Register Updates

A08 (FY25 GM Adj 24.4%) and A09 (no accounting irregularities) confirmed; A14 (ROIC 19.5%) computed.

#### Tables and Calculations

##### 7-Year Annual P&L Snapshot

| FY | Rev ($M) | GP ($M) | GM | OpInc ($M) | OpM | NetInc ($M) | NM | EPS Diluted | OCF ($M) | FCF ($M) | FCF M |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 1,308 | 326 | 24.9% | 191 | 14.6% | 150.5 | 11.5% | 5.46 | 198 | 127 | 9.7% |
| 2020 | 1,334 | 358 | 26.8% | 176 | 13.2% | 137.0 | 10.3% | 4.97 | 171 | 88 | 6.6% |
| 2021 | 1,467 | 387 | 26.4% | 186 | 12.7% | 142.3 | 9.7% | 5.16 | 174 | 86 | 5.9% |
| 2022 | 1,676 | 356 | 21.2% | 112 | 6.7% | 89.6 | 5.4% | 3.25 | 102 | (30) | (1.8%) |
| 2023 | 1,823 | 389 | 21.3% | 142 | 7.8% | 111.3 | 6.1% | 4.04 | 226 | 136 | 7.4% |
| 2024 | 1,872 | 432 | 23.1% | 199 | 10.7% | 158.6 | 8.5% | 5.76 | 252 | 184 | 9.8% |
| 2025 | 1,909 | 456 | 23.9% | 220 | 11.5% | 167.3 | 8.8% | 6.07 | 262 | 204 | 10.7% |

##### Balance Sheet Snapshot (FY25 end)

| Item | $M | % of Assets |
|---|---|---|
| Cash & equivalents | 161.5 | 12.7% |
| Inventory | 169.3 | 13.3% |
| AR + other current | 112.8 | 8.9% |
| PP&E (net) | 534.5 | 41.9% |
| Goodwill | 222.8 | 17.5% |
| Other intangibles + LT | 73.8 | 5.8% |
| **Total Assets** | **1,274.7** | **100%** |
| AP | 118.0 | 9.3% |
| Other CL | 68.3 | 5.4% |
| LT Debt | 42.7 | 3.3% |
| Other LT Liab | 47.2 | 3.7% |
| Stockholders' Equity | 998.5 | 78.3% |
| **Total Liab + Equity** | **1,274.7** | **100%** |

##### Returns vs. Peer Set (FY25)

| Metric | MZTI | SJM | HRL | MKC | FLO |
|---|---|---|---|---|---|
| Revenue ($B) | 1.91 | ~8.2 | ~12.2 | ~6.7 | ~5.1 |
| ROIC | 19.5% | ~9% | ~12% | ~10% | ~10% |
| FCF margin | 10.7% | ~7% | ~10% | ~8% | ~5% |
| Op margin | 11.5% | ~17% | ~12% | ~14% | ~9% |
| Net cash / (debt) | +$118M | levered | net cash | net debt | net debt |

MZTI's ROIC stands out across the peer set; the gross margin discount reflects Foodservice mix, not weak unit economics.

#### Open Questions and Data Gaps

- Step 09 (Returns on Capital) will revisit ROIC with deeper sensitivity testing and segment-level returns where possible.
- Working capital trajectory needs Q-by-Q view to assess inventory normalization rate — built in Step 05.
- M&A treatment in invested capital is conservative (full goodwill); could be sensitivity-tested in Step 09.

#### Next-Step Dependencies

Step 05 will deepen Q-level trend analysis; Step 06 will examine balance sheet/dilution structure in detail; Step 09 will compute ROIC under multiple definitions and gauge durability.

#### Source Index

Inheriting [S1]–[S10]. No new sources added in Step 04.

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/LANC/fundamental

## Navigation

- Overview: /stocks/LANC
- Financials (this page): /stocks/LANC/financials
- Thesis: /stocks/LANC/thesis
- Investment Memo: /stocks/LANC/memo
- Coverage universe: /stocks